Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Ugeskrift for Laeger|July 11, 1998
[Frequent mutation doubles the risk of ischemic heart disease in women]H H Wittrup, A Tybjaerg-Hansen, S Abildgaard, et al.
Journal of Medical Genetics|September 25, 2010
Wide spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular cardiomyopathyA H Christensen, M Benn, H Bundgaard, et al.
The Journal of Clinical Investigation|April 1, 1997
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart diseaseH H Wittrup, A Tybjaerg-Hansen, S Abildgaard, et al.
Atherosclerosis|February 13, 2001
Apolipoprotein E genotypes predict attendance rates at lipid clinicR Frikke-Schmidt, H H Wittrup, A Tybjaerg-Hansen, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2001
Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart StudyA A Sethi, B G Nordestgaard, B Agerholm-Larsen, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|April 8, 1999
Mutational analysis of the proopiomelanocortin gene in Caucasians with early onset obesityS M Echwald, T I Sørensen, T Andersen, et al.
The Journal of Clinical Investigation|June 15, 1997
A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart StudyA Tybjaerg-Hansen, B Agerholm-Larsen, S E Humphries, et al.
Journal of Internal Medicine|January 5, 2011
Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-upA Langsted, J J Freiberg, A Tybjaerg-Hansen, et al.
Circulation|May 20, 1997
ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart StudyB Agerholm-Larsen, B G Nordestgaard, R Steffensen, et al.
Annals of Internal Medicine|May 16, 2001
Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart StudyA A Sethi, A Tybjaerg-Hansen, M L Grønholdt, et al.
Pageof 7